On air · 1 of 3 networks
Definium Therapeutics
- definiumtx.com
- Healthcare & Life Sciences
- US
- 171 employees
Definium Therapeutics’s ads on LinkedIn, Meta and Google, recorded by adsrunning. Browse the latest here for free. Sign up free to see all 53. Watch Definium Therapeutics with Starter to get each new one in your feed.
Watchlist with Starter · $49/mo
| Network | Status | Live ads | Nov 2025LinkedIn activity · 52 weeksOct 2026 | Checked | Next step |
|---|---|---|---|---|---|
| Running | 53 | Checked 30 Oct 2026 | See all 53 ads → | ||
| Meta | Not checked | — | |||
| None recorded | 0 | No ads found on the Google Ads Transparency Center | Checked 26 Oct 2026 | Collect them with the API → |
Definium Therapeutics has 53 live LinkedIn ads. We recorded no Google ads on 26 Oct 2026.
Latest ads
- LINKEDIN · IMAGERecorded 8 Oct 2026
A Breakthrough Therapy designation only matters if we can get treatment to the patients who need it following approval. We need treatment frameworks that maintain high safety standards and ensure feasible implementation across diverse healthcare environments. In the latest edition of Forward Focus, I explore how we might bridge breakthrough clinical science and real-world delivery through evidence-led, scalable care models. Read the article here: https://bit.ly/4yXKQz5 #MentalHealth #DefiniumTherapeutics #Psychedelics #HealthcareInnovation #MDD #Depression #GAD #Anxiety
- LINKEDIN · IMAGERecorded 15 Sept 2026
Our positive Phase 3 Emerge results are an important milestone for Definium, but they also hold the potential to stand for something much bigger. In my latest edition of Forward Focus, I ask whether the standards we've long used to measure success in psychiatry are ambitious enough—and whether the field is ready to aim higher than incremental gains. Read more about the inflection point we’re standing within here: https://bit.ly/4vj7WOv #MentalHealth #DefiniumTherapeutics #Psychedelics #HealthcareInnovation #MDD #Depression
- LINKEDIN · VIDEORecorded 15 Sept 2026
#Sponsored At Definium, we’re advancing a deeper understanding of mental health through rigorous science and innovation. Hear from Rakesh Jain, MD, MPH, on why neuroplasticity is important as we continue our efforts to better understand and address mental health disorders. Explore how we’re Rerouting Minds.
- LINKEDIN · VIDEORecorded 15 Sept 2026
#Sponsored Rakesh Jain, MD, MPH, explores the "psychedelic renaissance,” in which treatments like pharmaceutical LSD are re-emerging with rigorous research. Clinicians must objectively evaluate this investigational compound’s potential to expand our patient toolkit. Explore this full-circle moment through Rerouting Minds.
- LINKEDIN · VIDEORecorded 15 Sept 2026
#Sponsored Our partner, Rakesh Jain, MD, MPH, explores how psychedelics like LSD are thought to induce neuroplasticity, the brain’s ability to adapt. This potential for adaptive change may help address unmet patient need in the mental health space. Explore the science of Rerouting Minds.
- LINKEDIN · IMAGERecorded 15 Sept 2026
#Sponsored The potential of pharmaceutical psychedelics like LSD in mental health is evolving and through ongoing research, could widen possibilities for patients facing persistent unmet needs. Learn more about how we’re Rerouting Minds here: https://bit.ly/4qqoLVo
6 of 53 adsSign up to see every Definium Therapeutics ad, filter by format and date, and get alerts on new ones.
See all 53 adsWatch the companies you care about.
Filter every ad by industry, country, format and network, and get alerts when a company you watch starts running new ads.